SIGIRR, a negative regulator of Toll-like receptor–interleukin 1 receptor signaling

被引:0
|
作者
David Wald
Jinzhong Qin
Zhendong Zhao
Youcun Qian
Mayumi Naramura
Liping Tian
Jennifer Towne
John E Sims
George R Stark
Xiaoxia Li
机构
[1] Cleveland Clinic Foundation,Department of Immunology
[2] Amgen Corporation,undefined
来源
Nature Immunology | 2003年 / 4卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The Toll-like receptor–interleukin 1 receptor signaling (TLR–IL-1R) receptor superfamily is important in differentially recognizing pathogen products and eliciting appropriate immune responses. These receptors alter gene expression, mainly through the activation of nuclear factor-κB and activating protein 1. SIGIRR (single immunoglobulin IL-1R-related molecule), a member of this family that does not activate these factors, instead negatively modulates immune responses. Inflammation is enhanced in SIGIRR-deficient mice, as shown by their enhanced chemokine induction after IL-1 injection and reduced threshold for lethal endotoxin challenge. Cells from SIGIRR-deficient mice showed enhanced activation in response to either IL-1 or certain Toll ligands. Finally, biochemical analysis indicated that SIGIRR binds to the TLR–IL-1R signaling components in a ligand-dependent way. Our data show that SIGIRR functions as a biologically important modulator of TLR–IL-1R signaling.
引用
收藏
页码:920 / 927
页数:7
相关论文
共 50 条
  • [21] Differential regulation of interleukin 1 receptor and Toll-like receptor signaling by MEKK3
    Huang, QJ
    Yang, JH
    Lin, Y
    Walker, C
    Cheng, JK
    Liu, ZG
    Su, B
    NATURE IMMUNOLOGY, 2004, 5 (01) : 98 - 103
  • [22] Differential regulation of interleukin 1 receptor and Toll-like receptor signaling by MEKK3
    Qiaojia Huang
    Jianhua Yang
    Yong Lin
    Christopher Walker
    Jinke Cheng
    Zheng-gang Liu
    Bing Su
    Nature Immunology, 2004, 5 : 98 - 103
  • [23] Molecular Interactions in Interleukin and Toll-like Receptor Signaling Pathways
    Snyder, Greg A.
    Sundberg, Eric J.
    CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (08) : 1244 - 1258
  • [24] Toll-like Interleukin 1 Receptor Regulator Is an Important Modulator of Inflammation Responsive Genes
    Kashem, Mohammad Abul
    Li, Hongzhao
    Toledo, Nikki Pauline
    Omange, Robert Were
    Liang, Binhua
    Liu, Lewis Ruxi
    Li, Lin
    Yang, Xuefen
    Yuan, Xin-Yong
    Kindrachuk, Jason
    Plummer, Francis A.
    Luo, Ma
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [25] Negative regulatory approaches to the attenuation of Toll-like receptor signaling
    Muhammad Ayaz Anwar
    Shaherin Basith
    Sangdun Choi
    Experimental & Molecular Medicine, 2013, 45 : e11 - e11
  • [26] Negative regulatory approaches to the attenuation of Toll-like receptor signaling
    Anwar, Muhammad Ayaz
    Basith, Shaherin
    Choi, Sangdun
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2013, 45 : e11 - e11
  • [27] Toll/Interleukin-1 Receptor Domain Dimers as the Platform for Activation and Enhanced Inhibition of Toll-like Receptor Signaling
    Fekonja, Ota
    Bencina, Mojca
    Jerala, Roman
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (37) : 30993 - 31002
  • [28] Toll-like receptor 4, but not toll-like receptor 2, is a signaling receptor for Escherichia and Salmonella lipopolysaccharides
    Tapping, RI
    Akashi, S
    Miyake, K
    Godowski, PJ
    Tobias, PS
    JOURNAL OF IMMUNOLOGY, 2000, 165 (10): : 5780 - 5787
  • [29] The role of interleukin-1 receptor-associated kinases in toll-like receptor signaling pathway
    Wang, H.
    Mothswene, G. P.
    George, J.
    Kubarenko, A. V.
    Rautanen, A.
    Mills, T. C.
    Hill, A. V. S.
    Gay, N. J.
    Weber, A. N. R.
    IMMUNOLOGY, 2011, 135 : 107 - 107
  • [30] Impaired monocyte Toll-like receptor-4 signaling in trauma and sepsis: Is SIGIRR the answer?
    Wang, Jacob E.
    Dahle, Maria K.
    Aasen, Angar O.
    CRITICAL CARE MEDICINE, 2006, 34 (09) : 2498 - 2500